Normand Balthazard
Chief Executive Officer bij Prognomix, Inc.
Profiel
Normand Balthazard is the founder of CryoCath Technologies, Inc., ConjuChem, Inc., Biorthex, Inc., Intellivax International, Inc., and Origenix Technologies, Inc. Currently, he is the Co-Chief Executive Officer at Prognomix, Inc. In the past, he served as the President & Chief Executive Officer at BioCapital Investment Advisors, Inc. from 2002 to 2005.
He was also the Chairman, President, Secretary & Treasurer at Contact Image Corp.
from 2004 to 2007.
Additionally, he served as a Director at Savaria Corp.
from 2003 to 2010.
Actieve functies van Normand Balthazard
Bedrijven | Functie | Begin |
---|---|---|
Origenix Technologies, Inc. | Corporate Officer/Principal | - |
Intellivax International, Inc.
Intellivax International, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Intellivax International, Inc. is a Canadian company that develops nasal spray vaccines. The private company is based in Laval, Canada. The company was founded by George H. Lowell. Intellivax International was acquired by ID Biomedical Corp., part of GSK Plc from December 13, 2005 on May 16, 2001 for $15.44 million. | Corporate Officer/Principal | - |
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Chief Executive Officer | - |
Eerdere bekende functies van Normand Balthazard
Bedrijven | Functie | Einde |
---|---|---|
SAVARIA CORPORATION | Director/Board Member | 01-03-2010 |
Contact Image Corp.
Contact Image Corp. Commercial Printing/FormsCommercial Services Contact Image Corp. provides digital and fabric printing services. It offers a range of printing services including fabric printing, textile printing, and media printing services. The company was founded in 1979 and is headquartered in Ville Mont-Royal, Canada. | Chairman | 23-03-2007 |
BioCapital Investment Advisors, Inc.
BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | President | 31-12-2005 |
Biorthex, Inc.
Biorthex, Inc. Medical SpecialtiesHealth Technology Biorthex, Inc. designs, develops, manufactures, and markets surgical products for the treatment of spinal disorders. Its products include Actipore PLFx, PLF, and ACF systems. The company was founded by Charles H. Rivard on November 9, 1993 and is headquartered in Laval, Canada. | Corporate Officer/Principal | - |
CryoCath Technologies, Inc.
CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Founder | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SAVARIA CORPORATION | Consumer Durables |
Bedrijven in privébezit | 8 |
---|---|
CryoCath Technologies, Inc.
CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Health Technology |
ConjuChem, Inc.
ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides. | Health Technology |
Biorthex, Inc.
Biorthex, Inc. Medical SpecialtiesHealth Technology Biorthex, Inc. designs, develops, manufactures, and markets surgical products for the treatment of spinal disorders. Its products include Actipore PLFx, PLF, and ACF systems. The company was founded by Charles H. Rivard on November 9, 1993 and is headquartered in Laval, Canada. | Health Technology |
BioCapital Investment Advisors, Inc.
BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | Finance |
Intellivax International, Inc.
Intellivax International, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Intellivax International, Inc. is a Canadian company that develops nasal spray vaccines. The private company is based in Laval, Canada. The company was founded by George H. Lowell. Intellivax International was acquired by ID Biomedical Corp., part of GSK Plc from December 13, 2005 on May 16, 2001 for $15.44 million. | Health Technology |
Contact Image Corp.
Contact Image Corp. Commercial Printing/FormsCommercial Services Contact Image Corp. provides digital and fabric printing services. It offers a range of printing services including fabric printing, textile printing, and media printing services. The company was founded in 1979 and is headquartered in Ville Mont-Royal, Canada. | Commercial Services |
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
Origenix Technologies, Inc. |